Clinical Trial Update: Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing zoledronic acid in patients with prostate cancer and bone metastases has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prostate Cancer Patients With Bone Metastasis | Phase 4 | Status: COMPLETED